ArticleCancer gene therapy2021

B-cell clonogenic activity of HIV-1 p17 variants is driven by PAR1-mediated EGF transactivation.

Cinzia Giagulli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.